Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?
- PMID: 30402413
- PMCID: PMC6209691
- DOI: 10.5125/jkaoms.2018.44.5.220
Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?
Abstract
Objectives: The aim of this study was to determine the incidence and characteristics of second primary malignancy (SPM) in patients with head and neck squamous cell carcinoma treated at a tertiary care hospital.
Materials and methods: We retrospectively reviewed the medical records of 221 patients who underwent surgery with or without adjuvant treatment for head and neck cancer from 2000 to 2002. Data of age, sex, risk factors, sites of primary and SPM, TNM stage of primary tumor, incidence of SPM, and survival were collected from medical charts.
Results: Eighteen patients developed SPM during a median follow-up of 67 months, with an overall incidence of 8.14%. In addition, 77.7% of SPMs occurred in the oral cavity, followed by 11% in the lungs. The 5-year overall survival after the diagnosis of SPM in the head or neck was 70%, compared to 30% for SPM in other body regions.
Conclusion: Considering a high incidence of SPM, i.e., 8.14%, in a mean follow-up period of 67 months suggests the need for long-term follow-up. Since treatment of SPM has shown an acceptable survival rate, early detection and curative therapy should be emphasized.
Keywords: Second primary malignancy; Survival rate; Survivorship.
Conflict of interest statement
Conflict of Interest: No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).PLoS One. 2015 Jul 28;10(7):e0134160. doi: 10.1371/journal.pone.0134160. eCollection 2015. PLoS One. 2015. PMID: 26218068 Free PMC article.
-
Incidence of second primary malignant neoplasm in Malwa region of central India.J Cancer Res Ther. 2018 Jul-Sep;14(5):999-1004. doi: 10.4103/0973-1482.183560. J Cancer Res Ther. 2018. PMID: 30197338
-
Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.Otolaryngol Head Neck Surg. 2013 Oct;149(4):579-86. doi: 10.1177/0194599813496373. Epub 2013 Jul 2. Otolaryngol Head Neck Surg. 2013. PMID: 23820107
-
Synchronous and metachronous head and neck carcinomas.Cancer. 1994 Oct 1;74(7):1933-8. doi: 10.1002/1097-0142(19941001)74:7<1933::aid-cncr2820740718>3.0.co;2-x. Cancer. 1994. PMID: 8082099 Review.
-
Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.Curr Med Res Opin. 2012 Dec;28(12):1899-909. doi: 10.1185/03007995.2012.746218. Epub 2012 Nov 23. Curr Med Res Opin. 2012. PMID: 23121148 Review.
Cited by
-
Long-Term Survival in Metachronous Primary Malignancies: Stage III Nasopharyngeal Cancer and Stage IV Non-Small-Cell Lung Cancer.J Clin Med. 2025 May 9;14(10):3299. doi: 10.3390/jcm14103299. J Clin Med. 2025. PMID: 40429295 Free PMC article.
-
Mutagen sensitivity and risk of second cancer in younger adults with head and neck squamous cell cancer: 15-year results.Strahlenther Onkol. 2022 Sep;198(9):820-827. doi: 10.1007/s00066-022-01917-2. Epub 2022 Mar 31. Strahlenther Onkol. 2022. PMID: 35357513 Free PMC article.
References
-
- Chu PY, Chang SY, Huang JL, Tai SK. Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx. Am J Otolaryngol. 2010;31:168–174. - PubMed
-
- Fujisawa R, Shibuya H, Harata N, Yuasa-Nakagawa K, Toda K, Hayashi K. Chronological shifts and changing causes of death after radiotherapy for early-stage oral cancer. Int J Clin Oncol. 2014;19:24–29. - PubMed
-
- Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74:1933–1938. - PubMed
-
- Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 1989;17:449–456. - PubMed
-
- Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989;17:691–694. - PubMed